Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.47 |
| ▸ | MLNR | O43193 | 1/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1560487 | 0.98 | LTA4H (0.46) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL27788476 | 0.96 | LTA4H (0.44) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL2279832 | 0.94 | LTA4H (0.47) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL27788474 | 0.91 | LTA4H (0.43) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL10880957 | 0.85 | LTA4H (0.41) | LTA4HKCNA3TSHR | |
| SCHEMBL1561622 | 0.81 | MAPT (0.41) | NR1I2CNR1 | |
| SCHEMBL8715173 | 0.76 | CA4 (0.42) | LTA4HALDH1A1LMNAKCNA3TSHR | |
| SCHEMBL3681302 | 0.74 | ALDH1A1 (0.50) | ESR1CHRM2ADRA2AADORA3CHRM1 | |
| SCHEMBL3689630 | 0.74 | ALDH1A1 (0.50) | ESR1CHRM2ADRA2AADORA3CHRM1 | |
| SCHEMBL3677578 | 0.74 | ALDH1A1 (0.50) | ESR1CHRM2ADRA2AADORA3CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9988331-B2 | Method for producing optically active, racemic menthol | BASF SE (DE) | 2018-06-05 | — | — | US | claimed |
| EP-2225192-B1 | METHOD FOR PRODUCING OPTICALLY ACTIVE, RACEMIC MENTHOL | BASF SE (DE) | 2017-05-03 | — | — | EP | claimed |
| CN-104211566-A | Method for producing optically active, racemic menthol | BASF SE | 2014-12-17 | — | — | CN | claimed |
| CN-101932543-B | Process for producing optically active, racemic menthol | BASF SE | 2014-07-30 | — | — | CN | claimed |
| US-20130046118-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE, RACEMIC MENTHOL | BASF SE (DE) | 2013-02-21 | — | — | US | claimed |
| US-8318985-B2 | Method for producing optically active, racemic menthol | BASF SE (DE) | 2012-11-27 | — | — | US | claimed |
| CN-101133067-B | Diarylphenoxyaluminum compounds | BASF AG | 2012-05-02 | — | — | CN | claimed |
| CN-101932543-A | Process for producing optically active, racemic menthol | BASF SE | 2010-12-29 | — | — | CN | claimed |
| US-20100249467-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE, RACEMIC MENTHOL | BASF SE (DE) | 2010-09-30 | — | — | US | claimed |
| EP-2225192-A2 | METHOD FOR PRODUCING OPTICALLY ACTIVE, RACEMIC MENTHOL | BASF SE (DE) | 2010-09-08 | — | — | EP | claimed |
| CN-101723809-A | Diaryl phenoxy aluminium compound | BASF SE | 2010-06-09 | — | — | CN | claimed |
| US-7608742-B2 | Diarylphenoxy aluminum compounds | BASF AKTIENGESELLSCHAFT (DE) | 2009-10-27 | — | — | US | claimed |
| WO-2009068444-A2 | METHOD FOR PRODUCING OPTICALLY ACTIVE, RACEMIC MENTHOL | BASF SE (DE) | 2009-06-04 | — | — | WO | claimed |
| EP-1858903-B1 | DIARYLPHENOXY ALUMINUM COMPOUNDS | BASF SE (DE) | 2008-10-08 | — | — | EP | claimed |
| US-20080167504-A1 | reacting a bis(diarylphenol) ligand with an alkylaluminum compound and/or a complex aluminum hydride; producing isopulegol by cyclization of citronellal in the presence of diarylphenoxyaluminum compounds as catalysts | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-10 | — | — | US | claimed |
| CN-101133067-A | Diarylphenoxyaluminum compounds | BASF AG (DE) | 2008-02-27 | — | — | CN | claimed |
| CN-107188781-B | Method for preparing isopulegol from citronellal | 万华化学集团股份有限公司 | 2020-07-24 | — | — | CN | disclosed |
| CN-108329194-A | A kind of citronellal prepares the method for isopulegol and its recovery method of catalyst | 万华化学集团股份有限公司 | 2018-07-27 | — | — | CN | disclosed |
| WO-2006092433-A1 | DIARYLPHENOXY ALUMINUM COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-08 | — | — | WO | disclosed |
| WO-2006092433-A1 | DIARYLPHENOXY ALUMINUM COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130046118-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE, RACEMIC MENTHOL | ADH1C, DHCR7, MSMO1 | LTA4H 658/4885MLNR 4797/4885NR1I2 1122/4885 |
| US-20080167504-A1 | reacting a bis(diarylphenol) ligand with an alkylaluminum compound and/or a complex aluminum hydride; producing isopulegol by cyclization of citronellal in the presence of diarylphenoxyaluminum compounds as catalysts | ACSL3, ACSL1, ACSL5 | LTA4H 15/4885MLNR 4359/4885NR1I2 2024/4885 |
| US-20100249467-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE, RACEMIC MENTHOL | ADH1C, DHCR7, MSMO1 | LTA4H 658/4885MLNR 4797/4885NR1I2 1122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.